Vivani Medical is trading at $1.34, 7.20% up, on September 11, 2026, amid firmer pre-market indices and broader risk-on sentiment.

  • A pre-recorded H.C. Wainwright company presentation became available at 7:00 a.m. Eastern Time on September 11, following the company’s September 3 announcement.
  • No clear new earnings, financing, regulatory, or clinical announcement was identified.
  • The move aligns with broader risk-on sentiment rather than a confirmed company-specific catalyst.